In this Point of View column,, CEO of Taconic Biosciences, explores redefining preclinical models for the future of drug development.

For the first time in its history, the 25th Infantry Division was able to successfully and rapidly forward-deploy a full high ...

When Maria looked at herself in the mirror for the first time after her mastectomy, she stood very still. One hand rested on ...

They answer different questions, require different expertise and fail in different ways. Here’s what happens when ...

I asked 5 data leaders about how they use AI to automate - and end integration nightmares ...

RA'ANANA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the commencement of an AME technology ...

PUCHHEIM, GERMANY - Newsaktuell - 18 November 2025 - ELATEC, a leading manufacturer of access technologies, specializing in RFID readers and credentials, has released its latest software development ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, ...

EU energy funding in the 2028–2034 budget is presented as crucial for reducing costs, strengthening competitiveness, ensuring ...

During last summer’s 12-day war between Iran, Israel, and the United States, the U.S. military supported Israeli air and ...

Allspring Common Stock Fund underperformed its benchmark in Q1 2026 due to negative stock selection. Read the full analysis ...